199
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and Characterization of Various Novel Derivatives of Dipyrimido[4,5-b:4',5'-e][1,4]thiazepine and Their Theoretical Evaluation as 15-Lipoxygenase Inhibitor

, , , ORCID Icon & ORCID Icon
Pages 288-301 | Received 26 Sep 2021, Accepted 23 Nov 2021, Published online: 04 Jan 2022

References

  • F. Peudru, J.-F. Lohier, M. Gulea, and V. Reboul, “Synthesis of 1,3-Thiazines by a Three-Component Reaction and Their Transformations into β-Lactam-Condensed 1,3-Thiazine and 1,4-Thiazepine Derivatives,” Phosphorus, Sulfur, and Silicon and the Related Elements 191, no. 2 (2016): 220–9.
  • W. Dehaen and T. H. Ngo, “1,4-Oxazepines and 1,4-Thiazepines,” Comprehensive Heterocyclic Chemistry III 13, no. 9 (2008): 255–98.
  • I. Ninomiya, T. Naito, and O. Miyata, Comprehensive Heterocyclic Chemistry II, 1,4-Oxazepines and 1,4-Thiazepines, vol. 9. (Elsevier, 1996), 21731. http://dx.doi.org/10.1016/b978-008096518-5.00217-3.31.
  • E. J. Warawa, B. M. Migler, C. J. Ohnmacht, A. L. Needles, G. C. Gatos, F. M. McLaren, C. L. Nelson, and K. M. Kirkland, “Behavioral Approach to Nondyskinetic Dopamine Antagonists: Identification of Seroquel,” Journal of Medicinal Chemistry 44, no. 3 (2001): 372–89.
  • N. Garg, T. Chandra, A. A. B. Jain, and A. Kumar, “Synthesis and Evaluation of Some New Substituted Benzothiazepine and Benzoxazepine Derivatives as Anticonvulsant Agents,” European Journal of Medicinal Chemistry 45, no. 4 (2010): 1529–35.
  • G. D. Mahale, Y. M. Kolekar, A. Kumar, D. Singh, K. M. Kodam, and S. B. Waghmode, “Synthesis and Antibacterial Activities of New Dibenzothiazepine Derivatives,” Cheminform 43, no. 4 (2012): 1196–201.
  • F. Shi, X. N. Zeng, X. D. Cao, S. Zhang, B. Jiang, W. F. Zheng, and S. J. Tu, “Design and Diversity-Oriented Synthesis of Novel 1,4-Thiazepan-3-Ones Fused with Bioactive Heterocyclic Skeletons and Evaluation of Their Antioxidant and Cytotoxic Activities,” Bioorganic & Medicinal Chemistry Letters 22, no. 1 (2012): 743–6.
  • A. Srikanth, S. Sarveswari, V. Vijayakumar, P. Gridharan, and S. Karthikeyan, “An Efficient L-Proline Catalyzed Synthesis of Pyrazolo[3,4-e][1,4]Thiazepine Derivatives and Their in Vitro Cytotoxicity Studies,” Medicinal Chemistry Research 24, no. 2 (2015): 553–62.
  • G. M. Pieper and W. Siebeneich, “Temocapril, an Angiotensin Converting Enzyme Inhibitor, Protects against Diabetes-Induced Endothelial Dysfunction,” European Journal of Pharmacology 403, no. 1-2 (2000): 129–32.
  • M. Arakawa, M. Sasaki, M. Ohmori, K. Harada, and A. Fujimura, “Pharmacokinetics and Pharmacodynamics of Temocapril during Repeated Dosing in Elderly Hypertensive Patients,” European Journal of Clinical Pharmacology 56, no. 11 (2001): 775–9.
  • S. Muthusamy, M. D. S. Kumar, and E. Suresh, “Synthesis of Indole Annulated [1,3]-Thiazaheterocycles and -Macrocycles via Ring-Closing Metathesis,” ChemistrySelect 1, no. 11 (2016): 2603–9.
  • X. Niu, B. Yang, Y. Li, S. Fang, Z. Huang, C. Xie, and C. Ma, “A Transition Metal-Free Tandem Process to Pyridazinopyrido[3,2-f][1,4]Thiazepine-Diones via Smiles Rearrangement,” Organic & Biomolecular Chemistry 11, no. 24 (2013): 4102–8.
  • Y. Kelgokmen and M. Zora, “Synthesis of 1,4-Thiazepines,” The Journal of Organic Chemistry 83, no. 15 (2018): 8376–89.
  • A. Sharma, D. Kishore, and B. Singh, “An Expedient Method for the Synthesis of 1,2,4-Triazolo-Fused 1,5-Benzodiazepine, 1,5-Benzoxazepine, and 1,5-Benzothiazepine Scaffolds: A Novel Seven-Membered Ring System of Biological Interest,” Journal of Heterocyclic Chemistry 55, no. 3 (2018): 586–92.
  • R. Saini, S. R. Malladi, and N. Dharavath, “Diversity-Oriented One-Pot Synthesis of Novel Imidazo[4′,5′:4,5]Benzo[e][1,4]Thiazepinones and Benzo[d]Imidazolyl Thiazolidinones through pTSA Promoted Cyclization and Evaluation of Antimicrobial and Anti-Inflammatory Activities,” Journal of Heterocyclic Chemistry 55, no. 7 (2018): 1579–88.
  • L. Wu, X. Yang, P. Qiujv, and G. Sun, “Synthesis and anti-Proliferative Activity Evaluation of Novel Benzo[d][1,3] Dioxoles-Fused 1,4-Thiazepines,” European Journal of Medicinal Chemistry 127 (2017): 599–605.
  • Y. M. Liu, C. H. Chen, T. K. Yeh, and J. P. Liou, “Synthesis and Evaluation of Novel 7H-Pyrrolo-[2,3-d]Pyrimidine Derivatives as Potential Anticancer Agents,” Future Medicinal Chemistry 11, no. 9 (2019): 959–74.
  • O. G. Shaaban, D. A. E. Issa, A. A. El-Tombary, S. M. A. E. Wahab, A. E. A. Wahab, and I. A. Abdelwahab, “Synthesis and Molecular Docking Study of Some 3,4-Dihydrothieno[2,3-d]Pyrimidine Derivatives as Potential Antimicrobial Agents,” Bioorganic Chemistry 88 (2019): 102934.
  • A. M. Farghaly, O. M. AboulWafa, Y. A. M. Elshaier, W. A. Badawi, H. H. Haridy, and H. A. Mubarak, “Design, Synthesis, and Antihypertensive Activity of New Pyrimidine Derivatives Endowing New Pharmacophores,” Medicinal Chemistry Research 28, no. 3 (2019): 360–79.
  • I. V. Ukrainets, N. L. Bereznyakova, G. Sim, and A. A. Davidenko, “Synthesis, Structure, and Analgesic Activity of Picolylamides of 2-Hydroxy-4-Oxo-4H-Pyrido-[1,2-a]Pyrimidine-3-Carboxylic Acids,” Pharmaceutical Chemistry Journal 52, no. 7 (2018): 601–5.
  • K. Somakala, S. Tariq, and M. Amir, “Synthesis, Evaluation and Docking of Novel Pyrazolo Pyrimidines as Potent p38α MAP Kinase Inhibitors with Improved anti-Inflammatory, Ulcerogenic and TNF-α Inhibitory Properties,” Bioorganic Chemistry 87 (2019): 550–9.
  • K. S. Raju, S. A. Reddy, G. Sabitha, V. S. Krishna, D. Sriram, K. B. Reddy, and S. R. Sagurthi, “Synthesis and Biological Evaluation of 1H-Pyrrolo[2,3-d]Pyrimidine-1,2,3-Triazole Derivatives as Novel anti-Tubercular Agents,” Bioorganic & Medicinal Chemistry Letters 29, no. 2 (2019): 284–90.
  • A. A. Fadda, S. B. Bondock, A. M. Khalil, and E. H. Tawfik, “Synthesis of Some New 1,2,3,4-Tetrahydropyrimidine-2-Thione and Their Thiazolo[3,2-a]Pyrimidine, Thiazino and Benzothiazepine Derivatives,” Journal of Heterocyclic Chemistry 50, no. 4 (2013): 838–43.
  • M. A. J. Duncton, L. M. Smith, S. B. Wizeman, A. Burns, H. Liu, Y. Mao, W. C. Wong, and A. S. Kiselyov, “Preparation of Substituted Pyrimido[4,5-b]-1,4-benzoxazepines, Thiazepines, and Diazepines via a Pictet-Spengler Cyclization,” The Journal of Organic Chemistry 70, no. 23 (2005): 9629–31.
  • E. A. El Rady, “A Facile and Simple Synthesis of Some New Pyridobenzothiazepine and Pyrimidobenzothiazepine Derivatives,” Phosphorus, Sulfur, and Silicon and the Related Elements 181, no. 10 (2006): 2213–24.
  • R. Fu, X. Xu, Q. Dang, and X. Bai, “Synthesis of Novel Tricyclic pyrimido[4,5-b][1,4]benzothiazepines via Bischler-Napieralski-Type Reactions,” The Journal of Organic Chemistry 70, no. 26 (2005): 10810–6.
  • T. S. Safonova, M. P. Nemeryuk, N. A. Grineva, A. F. Keremov, O. S. Anisimova, and N. P. Solov’eva, “Study of Nitrogen- and Sulfur-Containing Heterocycles. 54. Properties and Conversions of Pyrimido[4,5-b]-1,4-Benzothiazepines. Synthesis of a Novel Heterocyclic System: Pyrimido[5,4-c]Isoquinoline,” Chemistry of Heterocyclic Compounds 40, no. 12 (2004): 1609–17.
  • A. A. El-Emam, M. A. M. Massoud, E. R. El-Bendary, and M. A. El-Sayed, “Synthesis of Certain 6-(Arylthio) Uracils and Related Derivatives as Potential Antiviral Agents,” Bulletin of the Korean Chemical Society 25, no. 7 (2004): 991–6.
  • E. N. Segraves, R. R. Shah, N. L. Segraves, T. A. Johnson, S. Whitman, J. K. Sui, V. A. Kenyon, R. H. Cichewicz, P. Crews, and T. R. Holman, “Probing the Activity Differences of Simple and Complex Brominated Aryl Compounds against 15-Soybean, 15-Human, and 12-Human Lipoxygenase,” Journal of Medicinal Chemistry 47, no. 16 (2004): 4060–5.
  • S. Das, C. P. Roth, L. M. Wasson, and J. K. Vishwanatha, “Signal Transducer and Activator of Transcription-6 (STAT6) Is a Constitutively Expressed Survival Factor in Human Prostate Cancer,” The Prostate 67, no. 14 (2007): 1550–64.
  • T. M. A. Bocan, W. S. Rosebury, S. B. Mueller, S. Kuchera, K. Welch, A. Daugherty, and J. A. Cornicelli, “A Specific 15-Lipoxygenase Inhibitor Limits the Progression and Monocyte-Macrophage Enrichment of Hypercholesterolemia-Induced Atherosclerosis in the Rabbit,” Atherosclerosis 136, no. 2 (1998): 203–16.
  • K. V. Leyen, H. Y. Kim, S. R. Lee, G. Jin, K. Arai, and E. H. Lo, “Baicalein and 12/15-Lipoxygenase in the Ischemic Brain,” Stroke 37, no. 12 (2006): 3014–8.
  • E. Menteşe, N. Karaali, G. Akyüz, F. Yılmaz, S. Ülker, and B. Kahveci, “Synthesis and Evaluation of α-Glucosidase and Pancreatic Lipase Inhibition by Quinazolinone-Coumarin Hybrids,” Chemistry of Heterocyclic Compounds 52, no. 12 (2016): 1017–24.
  • H. Sadeghian and A. Jabbari, “15-Lipoxygenase Inhibitors: A Patent Review,” Expert Opinion on Therapeutic Patents 26, no. 1 (2016): 65–88.
  • A. Karimian, H. Eshghi, M. Bakavoli, A. Shiri, M. Saadatmandzadeh, T. Asghari, and H. Moradi, “Dipyrimido[4,5-b:5,4-e][1,4]thiazine: Synthesis and Their Enzyme Inhibitory Activity Assessment on Soybean 15-Lipoxygenase,” Journal of the Iranian Chemical Society 12, no. 9 (2015): 1501–8.
  • T. Asghari, M. Bakavoli, M. Rahimizadeh, H. Eshghi, S. Saberi, A. Karimian, F. Hadizadeh, and M. Ghandadi, “Synthesis and Evaluation of a New Series of 3,5-Bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and Their Cyclized Products 'Pyrimidinylthio Pyrimidotriazolothiadiazines' as 15- Lipo-Oxygenase Inhibitors,” Chemical Biology & Drug Design 85, no. 2 (2015): 216–24.
  • M. Bakavoli, M. Nikpour, M. Rahimizadeh, M. R. Saberi, and H. Sadeghian, “Design and Synthesis of Pyrimido[4,5-b][1,4]Benzothiazine Derivatives, as Potent 15-Lipoxygenase Inhibitors,” Bioorganic & Medicinal Chemistry 15, no. 5 (2007): 2120–6.
  • A. M. Fahim, E. H. I. Ismael, G. H. Elsayed, and A. M. Farag, “Synthesis, Antimicrobial, anti-Proliferative Activities, Molecular Docking and DFT Studies of Novel Pyrazolo[5,1-c][1, 2, 4]Triazine-3-Carboxamide Derivatives,” Journal of Biomolecular Structure and Dynamics (2021): 1–17.
  • A. M. Fahim, H. E. M. Tolan, H. Awad, and E. H. I. Ismael, “Synthesis, Antimicrobial and Antiproliferative Activities, Molecular Docking, and Computational Studies of Novel Heterocycles,” Journal of the Iranian Chemical Society 18, no. 11 (2021): 2965–81.
  • K. Saadat, A. Shiri, and B. Kovačević, “Substituted Troponimines: When Aromatization of the Conjugate Acid Leads to Very Strong Neutral Organic Superbases,” New Journal of Chemistry 42, no. 17 (2018): 14568–75.
  • M. Akbarzadeh, M. Bakavoli, H. Eshghi, A. Shiri, H. Azizollahi, and J. T. Mague, “Synthesis of 2-Substituted-4-Methyl-5,13-Dihydropyrimido[4′,5′:5,6][1,4]Thiazepino[2,3-b]Quinoxaline as a New Heterocyclic System,” Phosphorus, Sulfur, and Silicon and the Related Elements 193, no. 9 (2018): 545–51.
  • M. Keyhaniyan, A. Shiri, H. Eshghi, and A. Khojastehnezhad, “Synthesis, Characterization and First Application of Covalently Immobilized Nickel-Porphyrin on Graphene Oxide for Suzuki Cross-Coupling Reaction,” New Journal of Chemistry 42, no. 24 (2018): 19433–41.
  • S. Sheikhi-Mohammareh and A. Shiri, “An Alternative Regioselective Approach for the Synthesis of Highly Functionalized Derivatives of Pyrazolo[5,1-b]Purine Scaffold,” Journal of Heterocyclic Chemistry 55, no. 9 (2018): 2055–60.
  • M. Akbarzadeh, M. Bakavoli, H. Eshghi, and A. Shiri, “Synthesis of Novel Derivatives of (Benz)Imidazo[2,1-b]Pyrimido[4,5-d][1,3]Thiazine,” Journal of Chemical Research 41, no. 12 (2017): 730–3.
  • H. Taheri, A. Shiri, H. Eshghi, and S. Sheikhi-Mohammareh, “Fe (HSO4) 3-Catalyzed Direct Conversion of Aldehydes into Nitriles Using Hydroxylamine Hydrochloride,” Organic Chemistry Research 3, no. 1 (2017): 37–43.
  • S. S. Mozafari, A. Shiri, M. Bakavoli, M. Akbarzadeh, K. Saadat, and Y. Etemadi, “Synthesis and Density Functional Theory Study of [1,2,3]Triazolo[4,5-d][1,2,4] Triazolo[4,3-a]Pyrimidine Derivatives: A Novel Heterocyclic System,” Journal of Chemical Research 40, no. 10 (2016): 633–6.
  • M. Akbarzadeh, M. Bakavoli, H. Eshghi, A. Shiri, and J. Tajabadi, “Synthesis of Dihydrobenzo [b] Pyrimido [4, 5-e][1, 4] Thiazepines; Derivatives of a Novel Ring System,” Journal of Chemical Research 39, no. 9 (2015): 531–4.
  • S. Chandrappa, K. Vinaya, T. Ramakrishnappa, and K. S. Rangappa, “An Efficient Method for Aryl Nitro Reduction and Cleavage of Azo Compounds Using Iron Powder/Calcium Chloride,” Synlett 2010, no. 20 (2010): 3019–22.
  • A. Karimian, H. Eshghi, M. Bakavoli, and A. Shiri, “Synthesis of Pyrimido [4′, 5′: 2, 3][1, 4] Thiazepino [7, 6-b] Quinolines, Derivatives of a Novel Ring System,” Heterocyclic Communications 20, no. 5 (2014): 275–9.
  • K. Wolinski, J. F. Hinton, and P. Pulay, “Efficient Implementation of the Gauge-Independent Atomic Orbital Method for NMR Chemical Shift Calculations,” Journal of the American Chemical Society 112, no. 23 (1990): 8251–60.
  • A. D. Becke, “Density‐Functional Thermochemistry. III. The Role of Exact Exchange,” The Journal of Chemical Physics 98, no. 7 (1993): 5648–52.
  • M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, et al. Gaussian 09, Revis. E01, 2009. Wallingford: Gaussian, Inc.
  • Auto Dock Tools (ADT), the Scripps Research Institute. (USA, 2011). http://www.scripps.edu/pub/olson-web/doc/autodock/.
  • M. Iranshahi, A. Jabbari, A. Orafaie, R. Mehri, S. Zeraatkar, T. Ahmadi, M. Alimardani, and H. Sadeghian, “Synthesis and SAR Studies of Mono O-Prenylated Coumarins as Potent 15-Lipoxygenase Inhibitors,” European Journal of Medicinal Chemistry 57 (2012): 134–42.
  • G. M. Morris, H. Ruth, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, and A. J. Olson, “Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility,” Journal of Computational Chemistry 30, no. 16 (2009): 2785–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.